Aerie's eye drug meets main goal in late-stage study; shares jump

Sept 14 (Reuters) - Aerie Pharmaceuticals Inc said

on Wednesday its eye drug met the main goal in a late stage

study, sending its shares up 71 percent in extended trading.

Read more